Cyclo Therapeutics (CYTHW) Competitors $0.18 0.00 (0.00%) (As of 11/15/2024 ET) Add Compare Share Share Competitors Stock AnalysisChartCompetitorsFinancialsSEC FilingsShort InterestTrends CYTHW vs. ATNFW, LBPSW, AEHAW, AIMDW, ALVOW, ALVO, ARAV, ACABW, ACABU, and BFRIWShould you be buying Cyclo Therapeutics stock or one of its competitors? The main competitors of Cyclo Therapeutics include 180 Life Sciences (ATNFW), 4D pharma (LBPSW), Aesther Healthcare Acquisition (AEHAW), Ainos (AIMDW), Alvotech (ALVOW), Alvotech (ALVO), Aravive (ARAV), Atlantic Coastal Acquisition Corp. II (ACABW), Atlantic Coastal Acquisition Corp. II (ACABU), and Biofrontera (BFRIW). These companies are all part of the "pharmaceutical products" industry. Cyclo Therapeutics vs. 180 Life Sciences 4D pharma Aesther Healthcare Acquisition Ainos Alvotech Alvotech Aravive Atlantic Coastal Acquisition Corp. II Atlantic Coastal Acquisition Corp. II Biofrontera Cyclo Therapeutics (NASDAQ:CYTHW) and 180 Life Sciences (NASDAQ:ATNFW) are both medical companies, but which is the superior stock? We will compare the two companies based on the strength of their community ranking, media sentiment, risk, institutional ownership, valuation, profitability, dividends, earnings and analyst recommendations. Which has stronger earnings & valuation, CYTHW or ATNFW? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioCyclo Therapeutics$1.13MN/AN/AN/AN/A180 Life SciencesN/AN/AN/AN/AN/A Does the media prefer CYTHW or ATNFW? In the previous week, Cyclo Therapeutics and Cyclo Therapeutics both had 1 articles in the media. Cyclo Therapeutics' average media sentiment score of 1.89 beat 180 Life Sciences' score of 1.87 indicating that Cyclo Therapeutics is being referred to more favorably in the media. Company Overall Sentiment Cyclo Therapeutics Very Positive 180 Life Sciences Very Positive Is CYTHW or ATNFW more profitable? Company Net Margins Return on Equity Return on Assets Cyclo TherapeuticsN/A N/A N/A 180 Life Sciences N/A N/A N/A Does the MarketBeat Community prefer CYTHW or ATNFW? Cyclo Therapeutics and 180 Life Sciences both received 0 outperform votes by MarketBeat users. CompanyUnderperformOutperformCyclo TherapeuticsN/AN/A180 Life SciencesN/AN/A SummaryCyclo Therapeutics beats 180 Life Sciences on 2 of the 2 factors compared between the two stocks. Ad Genesis Gold GroupTrump’s Back, but DC’s Coming for Your Money!Trump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy with a heavy hand—building up infrastructure, slapping tariffs on imports, and going all-in on U.S. jobs. But here's the kicker: while Trump's focused on making America stronger, the Washington elite is ready to fight back…Get ahead of the game with 3 proven strategies to protect your retirement from Washington's next mov Get Cyclo Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for CYTHW and its competitors with MarketBeat's FREE daily newsletter. Email Address Media Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CYTHW vs. The Competition Export to ExcelMetricCyclo TherapeuticsDrug Manufacturers IndustryMedical SectorNASDAQ ExchangeMarket CapN/A$1.19B$5.15B$8.74BDividend YieldN/A3.13%5.18%4.08%P/E RatioN/A106.9962.6013.00Price / SalesN/A3,546.221,277.9088.72Price / CashN/A10.3339.7935.27Price / BookN/A3.196.455.92Net IncomeN/A$155.49M$119.73M$225.73M7 Day Performance-11.98%-0.77%-5.13%-1.34%1 Month Performance17.49%-2.67%-2.71%1.15%1 Year Performance-22.56%95.74%31.08%24.02% Cyclo Therapeutics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CYTHWCyclo TherapeuticsN/A$0.18flatN/AN/A$0.00$1.13M0.009Positive NewsATNFW180 Life SciencesN/A$0.01flatN/A-32.5%$0.00N/A0.007Gap UpLBPSW4D pharmaN/AN/AN/AN/A$0.00$522,000.000.00N/AGap DownAEHAWAesther Healthcare AcquisitionN/A$0.04flatN/AN/A$0.00N/A0.002Gap DownAIMDWAinosN/A$0.03flatN/A-94.2%$0.00$65,122.000.0040Positive NewsALVOWAlvotechN/A$3.10+6.9%N/A+98.1%$0.00$306.77M0.004Short Interest ↓Gap DownHigh Trading VolumeALVOAlvotech2.3606 of 5 stars$12.07+1.2%N/A+29.9%$0.00$93.38M-4.551,026News CoverageARAVAravive0.6902 of 5 stars$0.04flatN/AN/A$0.00$9.14M-0.0420High Trading VolumeACABWAtlantic Coastal Acquisition Corp. IIN/A$0.06flatN/A-10.3%$0.00N/A0.004Positive NewsACABUAtlantic Coastal Acquisition Corp. IIN/A$8.05-26.8%N/AN/A$0.00N/A0.004Gap DownBFRIWBiofronteraN/A$0.09+80.2%N/A+279.9%$0.00$35.24M0.0070Gap Down Related Companies and Tools Related Companies ATNFW Competitors LBPSW Competitors AEHAW Competitors AIMDW Competitors ALVOW Competitors ALVO Competitors ARAV Competitors ACABW Competitors ACABU Competitors BFRIW Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:CYTHW) was last updated on 11/17/2024 by MarketBeat.com Staff From Our PartnersThere is a little known company that is changing warfareWith geo - political instability around the world investors are flocking to defense contract stocks. There...Reticulate | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cyclo Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Cyclo Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free CYTHW Stock Alerts